Oncotarget, 8(11), 18381-18398. Impact Journals LLC Fagerholm, R, Khan, S, Schmidt, M K, García-Closas, M, Heikkilä, P, Saarela, J, Beesley, J, Jamshidi, M, Aittomäki, K, Liu, J, Ali, H R, Andrulis, I L, Beckmann, M W, Behrens, S, Blows, F M, Brenner, H, Chang-Claude, J, Couch, F J, Czene, K, Fasching, P A, Figueroa, J, Floris, G, Glendon, G, Guo, Q, Hall, P, Hallberg, E, Hamann, U, Holleczek, B, Hooning, M J, Hopper, J L, Jager, A, Kabisch, M, Keeman, R, Kosma, V-M, Lambrechts, D, Lindblom, A, Mannermaa, A, Margolin, S, Provenzano, E, Shah, M, Southey, M C, Dennis, J, Lush, M, Michailidou, K, Wang, Q, Bolla, M K, Dunning, A M, Easton, D F & Pharoah, P D P & Chenevix-Trench, G 2017, ' TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer ', Oncotarget, vol. 8, no. 11, pp. 18381-18398 . https://doi.org/10.18632/oncotarget.15110 Oncotarget